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In this issue of Chemistry & Biology, Duquesne and colleagues [1] describe the biosynthetic machin-
ery of microcin J25, an antibacterial peptide that adopts an exceptional three-dimensional structure
resembling a knot. The dedicated enzymes, McjB and McjC, were identified and employed to
produce this modification in vitro.The problem of increasing antibacte-
rial resistance, that modern medicine
faces today, has resulted in quite
a number of studies that deal with nat-
ural antibacterial products and their
biosynthesis. Microcins are defined
as small antibacterial peptides that
are produced by members of the
Enterobacteriaceae. The designation
‘‘microcin’’ was coined to set off the
low molecular weight antibacterial
peptides (<10 kDa) against the large
protein bacteriocins (e.g., the colicins)
that are also produced by these bacte-
ria. All microcins are ribosomally syn-
thesized and they are often posttrans-
lationally modified. Themicrocin group
comprises peptides that differ widely
with respect to their structure and
mode of action. For example, microcin
B17, a peptide that contains thiazole
and oxazole rings, targets the DNA
gyrase, microcin C7, which carries
a C-terminal adenosine monophos-
phate, inhibits protein biosynthesis
[2], and microcin E492 permeabilizes
the cytoplasmic membrane in its
unmodified as well as in its modified
form [3].
Microcin J25 is characterized by
a very unusual and fascinating struc-734 Chemistry & Biology 14, July 2007 ªture: a so-called ‘‘lasso peptide’’ [4].
Lasso peptides are short peptides
(16–21 amino acids) that contain an
N-terminal ring structure that is closed
by an amide bond between the N-ter-
minal amino acid and the side chain
carboxyl group of a glutamic or as-
partic amino acid residue in position
8 or 9. The C-terminal tail is threaded
through this ring structure and forms
a loop or noose, which, in the case of
microcin J25, is stabilized by bulky ar-
omatic residues in the C terminus
(Phe19 and Tyr20) that anchor the
loop above and below the ring (Fig-
ure 1). The resulting backbone struc-
ture resembles a lasso and is very
stable, thus, even after cleavage of
the loop by proteases, the C-terminal
part will stay anchored in the ring [5].
Several other examples of lasso
peptides have been described so far.
Although their modes of action are
very diverse, themajority of these pep-
tides bind to proteins. For example, the
group includes MS-271, an inhibitor of
the calmodulin-activated myosin light
chain kinase [6], anantin, a peptide
binding to the atrial natriuretic factor
(ANF) [7], and two closely related pep-
tides, NP-06 and RP 71955, which are2007 Elsevier Ltd All rights reservedactive against human immunodefi-
ciency virus 1 [8, 9]. The lariatins A
and B [10] and microcin J25 are the
only lasso peptides with antibacterial
activity. Microcin J25 is produced by
and is active against Escherichia coli
strains. Furthermore, it inhibits growth
of someSalmonella serovars. It passes
the outermembrane, taking advantage
of the FhuA iron siderophore trans-
porter [11], and is taken up into the
cytoplasm via other membrane pro-
teins (Smb, TonB, ExbD and ExbB).
Intracellularly it acts as an inhibitor of
the RNA polymerase and stimulates
the production of superoxide [12].
The main producers of lasso pep-
tides characterized so far aremembers
of the actinobacteria and belong to the
genera Streptomyces, Microbiospora,
and Rhodococcus. In order to synthe-
size a lasso peptide, like microcin
J25, the prepeptide has to be folded
in the correct manner, with the N
terminus embracing the C terminus.
Subsequently, the leader peptide
cleavage and the ring formation need
to take place. The enzymes that
catalyze these maturation steps were
unknown until now. For the first
time, Duquesne and coworkers [1]
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tion enzymes in vivo and in vitro, which
marks amajor progress in our compre-
hension of the biosynthesis of lasso
peptides.
McjB and McjC are encoded in the
open reading frames adjacent to the
structural gene of McjA, but they are
transcribed divergently. A fourth pro-
tein, McjD, is a dedicated transport
protein, also involved in producer
self- protection [13]. First, the authors
performed knockout and complemen-
tation experiments with McjB and
McjD, which demonstrated that both
enzymes are essential for the matura-
tion of microcin J25. Next, both en-
zymes were cloned, expressed as
His-tag proteins, and purified. The au-
thors also cloned the His-tag construct
of the precursor peptide of microcin
J25, a prepeptide consisting of 58
amino acids. This prepeptide, with
a 37 amino acid leader sequence,
does not display antibacterial activity
and seems to be quickly degraded by
proteases. In vitro both enzymes, as
well as ATP, MgCl2, and DTT, were re-
quired for the maturation reaction to
proceed and yield the active peptide,
indicating that the combination of
McjB and McjC is sufficient for the
complete posttranslational modifica-
tion. The presence of the leader se-
quence was essential for the modifica-
tion. Finally, the group tested the
influence of protease inhibitors on
the reaction, since the cleavage of the
leader had to precede ring formation,
and demonstrated that inhibitors of
Figure 1. The Structure of Microcin J25
The N-terminal amide ring is shown in white
and the C-terminal loop is shown in gray.serine proteases arrested the modifi-
cation reactions as expected.
Many of the data shown here are
reminiscent of results that were ob-
tainedwith small Gram-positive bacte-
riocins, the lantibiotics. The mature
forms of these peptides contain in-
tramolecular thioether ring structures
that are introduced by dedicated en-
zymes [14]. Lantibiotics also pos-
sess ribosomally made prepeptides
that comprise N-terminal leader se-
quences and are considerably longer
than the mature peptides. The leader
peptides are needed for recognition
by the modification enzymes and the
unmodified or partially modified pre-
peptides are not antibacterially active
and often susceptible to proteolytic
degradation.
Since it had not been possible to iso-
late and analyze the intermediate prod-
uct, in silico analyses were performed
to obtain information on the substrate
specificities of the two enzymes.
McjC shows similarity to b-lactam syn-
thetases and class B asparagine syn-
thetases. Both enzyme classes cata-
lyze the formation of the amide bonds
and therefore McjC may be involved
in formation of the N-terminal ring.
McjBbears resemblance to transgluta-
minases and cysteine proteases and
might act as the leader peptidase.
However, the in vitro reaction was un-
able to proceed when serine protease
inhibitors were added. This might indi-
cate that either McjB is a serine, and
not a cysteine, protease, or McjA,
which shows some similarity to serine
proteases, acts autocatalytically. This
issue is yet to be resolved andwarrants
further work.
Surprisingly, similar gene clusters
encoding putative lasso peptides
were found in several genomes. They
are present in the g-proteobacteria
Burkholderia thailandiensis, B. pseu-
domallei, and B. mallei, as well as in
the a-proteobacteria Caulobacter sp.
K31 and the marine bacterium Sphin-
gopyxis alaskensis. Although not all of
these gene clusters contain the homol-
ogous export protein, their presence
clearly indicates that lasso peptides
are far more widespread than formerly
thought.
The successful in vitro reconstitution
of the lasso peptide posttranslationalChemistry & Biology 14, July 2007 ªmodification system now opens the
possibility for testing these enzymes
in the in vitro peptide engineering as-
says. Therefore, this paper represents
a stepping-stone that might enable
biotechnology to ‘‘tie the knot’’ in
peptides and design novel peptides
with an enhanced stability, defined
conformations, and yet unforeseen
properties.
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